Stratum Nutrition expands to Netherlands to foster EU collaboration
Key takeaways
- Stratum Nutrition has opened an office in the Netherlands to strengthen its European presence.
- Its portfolio includes clinically backed ingredients like NEM eggshell membrane for joint health and Ovolux for beauty-from-within.
- The Netherlands’ central location and strong nutraceutical sector will support R&D, partnerships, and regional growth.
US-based Stratum Nutrition has expanded into the Netherlands with a new office to boost its European presence. With its clinically validated nutraceuticals, the move seeks to bring local support and innovation, focused on joint health, cognitive support, beauty-from-within, and overall health.
The company’s key products include NEM eggshell membrane for joint health, recognized for effectiveness and safety, and inner beauty solution Ovolux. These multicollagen products include types I, V, and X to support joints, hair, skin, and nails.
“Expanding into Europe marks an important milestone in Stratum Nutrition’s growth journey,” says Arun Nair, Stratum Nutrition’s chief commercial officer. “Our goal has always been to deliver trusted, high-quality ingredients supported by strong science.”
“This new location allows us to better serve our partners in Europe and nearby regions, making our portfolio more accessible to those seeking effective solutions in the nutraceutical space for both human and pet applications.”
Connectivity center
According to the company, the Netherlands is a central location with connectivity to several markets. Its strong nutraceutical base also enables further R&D while strengthening partnerships.
“As the new European Team of Stratum Nutrition, we are excited to support Stratum in bringing their innovative science to the European market,” comments Betsi Wumba, international business development strategist for Stratum Nutrition.
“With our expertise in navigating Europe’s diverse business landscape, we see tremendous opportunities for Stratum to connect with local partners, address market needs, and contribute to the growth of the industry across the region.”
The company notes that the business move shows its long-term commitment to securing human health through innovation and research. It adds that it is committed to expanding its ingredient portfolio and deepening European partnerships.
